Philip Tsai Immunome Inc. (IMNM) insider trading activity
Philip Tsai is Chief Technology Officer of Immunome Inc.. Currently has a direct ownership of 33,300 shares of IMNM, which is worth approximately $241,425. The most recent transaction as insider was on Mar 24, 2025, when has been sold 12,300 shares (Common Stock) at a price of $8.42 per share, resulting in proceeds of $103,566. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
33.3K
58.57%
3M change
n/a
12M change
Total Value Held
$241,425
Philip Tsai Transaction History
PT
Philip Tsai
Chief Technology Officer
Bothell, WA